Cara Therapeutics (CARA) Stock Price, Quote & News

Company Profile

Cara Therapeutics, Inc. operates as a biopharmaceutical company that focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica....

Industry: Biotechnology

Sector: Healthcare

Phone: (203) 406-3700

Website: www.caratherapeutics.com

Address:

400 Atlantic Street, Suite 500, Stamford, United States

Navadel_ Jun. 9 at 9:23 PM

$KLTO $CARA

0 · Reply

mtlewis May. 2 at 1:50 AM

$CARA this company no longer exists. The ticker is now TVRD, so these data are meaningless.

0 · Reply

Alex1183 Apr. 30 at 4:52 PM

$CARA PT is a high of $42 wow 🤯 maybe when I’m 94 yrs old the will be profitable

1 · Reply

Alex1183 Apr. 30 at 3:57 PM

$CARA in only down97% lets see this go to $800

1 · Reply

Estimize Apr. 30 at 1:06 PM

Wall St is expecting -2.40 EPS for $CARA Q1 [Reporting 05/13 AMC] http://www.estimize.com/intro/cara?chart=historical&metric_name=eps&utm_c

0 · Reply

Iamthecooler Apr. 29 at 9:27 PM

$CARA only 400% to go!

1 · Reply

OffComesTheShirt Apr. 28 at 7:49 PM

$CARA 14% Off Comes The Shirt

0 · Reply

mtlewis Apr. 27 at 2:49 AM

$CARA https://ir.tvarditherapeutics.com/static-files/59382a0d-c49b-4747-9e4c-a6870dba5caf

0 · Reply

Alex1183 Apr. 26 at 11:20 PM

$CARA my shares just got destroyed to a qtr of what I had , I for got about the 150k I lost here now I need the stock to hit like 800 to get my money back

3 · Reply

lonedaddy Apr. 23 at 9:13 PM

$CARA Ya think these guys would come out of the corner swinging but they just sitting in their corner twiddling thumbs like the previous management.

1 · Reply

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

TVRD

Apr 14, 2025, 11:50 AM EDT - 2 months ago

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics

Feb 20, 2025, 5:25 PM EST - 4 months ago

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA

Dec 27, 2024, 7:00 AM EST - 6 months ago

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split

Dec 18, 2024, 7:00 AM EST - 6 months ago

Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement

Jun 13, 2024, 12:21 PM EDT - 1 year ago

These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'

Jun 12, 2024, 4:19 PM EDT - 1 year ago

Cara Therapeutics discontinues study on a neurological condition as drug fails

Jun 12, 2024, 4:01 PM EDT - 1 year ago

Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica

May 13, 2024, 4:01 PM EDT - 1 year ago

Cara Therapeutics Reports First Quarter 2024 Financial Results

May 6, 2024, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024

Apr 2, 2024, 9:02 AM EDT - 1 year ago

Cara Therapeutics, Inc. (CARA) to Present at the 23rd Annual Needham Virtual Healthcare Conference

Apr 2, 2024, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 7:00 AM EST - 1 year ago

Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

Mar 4, 2024, 7:07 PM EST - 1 year ago

Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 4:01 PM EST - 1 year ago

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 12, 2024, 4:01 PM EST - 1 year ago

Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

Jan 22, 2024, 7:00 AM EST - 1 year ago

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

Dec 18, 2023, 7:00 AM EST - 1 year ago

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Nov 13, 2023, 7:20 PM EST - 1 year ago

Cara Therapeutics, Inc. (Cara) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:01 PM EST - 1 year ago

Cara Therapeutics Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

Oct 23, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023

Sep 25, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients

Aug 7, 2023, 6:13 PM EDT - 2 years ago

Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Cara Therapeutics Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors

Aug 2, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 24, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023

Jul 14, 2023, 5:11 PM EDT - 2 years ago

Cara Therapeutics Faces Uncertainty Despite Potential Reimbursement Extension For Korsuva

Jun 1, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics to Present at the Jefferies Healthcare Conference

May 18, 2023, 2:00 AM EDT - 2 years ago

Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

May 15, 2023, 7:31 PM EDT - 2 years ago

Cara Therapeutics, Inc. (CARA) Q1 2023 Earnings Call Transcript

May 15, 2023, 4:01 PM EDT - 2 years ago

Cara Therapeutics Reports First Quarter 2023 Financial Results

May 1, 2023, 9:20 AM EDT - 2 years ago

Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2023 Financial Results on May 15, 2023

May 1, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

Apr 10, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

Mar 14, 2023, 8:02 AM EDT - 2 years ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)

AHCO OPRX TKNO

Mar 14, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report

Mar 13, 2023, 9:00 AM EDT - 2 years ago

Cara Therapeutics: Looking To Place A Bid After A Big Miss On Earnings

Mar 7, 2023, 10:13 AM EST - 2 years ago

Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss

Mar 6, 2023, 8:44 PM EST - 2 years ago

Cara Therapeutics, Inc. (CARA) Q4 2022 Earnings Call Transcript

Mar 6, 2023, 4:01 PM EST - 2 years ago

Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

Feb 21, 2023, 7:00 AM EST - 2 years ago

Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Feb 8, 2023, 5:00 PM EST - 2 years ago

Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

Jan 17, 2023, 7:00 AM EST - 2 years ago

Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023

Jan 3, 2023, 7:00 AM EST - 2 years ago

Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference

Dec 29, 2022, 11:15 AM EST - 2 years ago

Cannabis REITs: Smoked Out

ACB AFCG BYND CGC CNBS CRON CWEB

Nov 7, 2022, 8:31 PM EST - 2 years ago

Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call Transcript

Navadel_ Jun. 9 at 9:23 PM

$KLTO $CARA

0 · Reply

mtlewis May. 2 at 1:50 AM

$CARA this company no longer exists. The ticker is now TVRD, so these data are meaningless.

0 · Reply

Alex1183 Apr. 30 at 4:52 PM

$CARA PT is a high of $42 wow 🤯 maybe when I’m 94 yrs old the will be profitable

1 · Reply

Alex1183 Apr. 30 at 3:57 PM

$CARA in only down97% lets see this go to $800

1 · Reply

Estimize Apr. 30 at 1:06 PM

Wall St is expecting -2.40 EPS for $CARA Q1 [Reporting 05/13 AMC] http://www.estimize.com/intro/cara?chart=historical&metric_name=eps&utm_c

0 · Reply

Iamthecooler Apr. 29 at 9:27 PM

$CARA only 400% to go!

1 · Reply

OffComesTheShirt Apr. 28 at 7:49 PM

$CARA 14% Off Comes The Shirt

0 · Reply

mtlewis Apr. 27 at 2:49 AM

$CARA https://ir.tvarditherapeutics.com/static-files/59382a0d-c49b-4747-9e4c-a6870dba5caf

0 · Reply

Alex1183 Apr. 26 at 11:20 PM

$CARA my shares just got destroyed to a qtr of what I had , I for got about the 150k I lost here now I need the stock to hit like 800 to get my money back

3 · Reply

lonedaddy Apr. 23 at 9:13 PM

$CARA Ya think these guys would come out of the corner swinging but they just sitting in their corner twiddling thumbs like the previous management.

1 · Reply

OffComesTheShirt Apr. 23 at 1:44 PM

$CARA 13% Off Comes The Shirt

0 · Reply

OffComesTheShirt Apr. 22 at 4:43 PM

$CARA 17% Off Comes The Pants.

0 · Reply

OffComesTheShirt Apr. 22 at 4:27 PM

$CARA 12% Off Comes The Shirt

0 · Reply

lonedaddy Apr. 21 at 7:36 PM

$CARA they have a new symbol up $TVRD

0 · Reply

lonedaddy Apr. 21 at 3:34 PM

$CARA WTF is with stocktwits TVRD isn't even listed or the CARA price updated. Did POSner get a new job running stocktwits?

0 · Reply

Iamthecooler Apr. 18 at 4:07 PM

$CARA TVRD ? They were so close its TURD

0 · Reply

lonedaddy Apr. 17 at 2:11 PM

$CARA ok TVRD management time to step up the PR game. You are public now, show your stuff! Get some interest going.

0 · Reply

topstockalerts Apr. 16 at 7:20 PM

$CARA $19 break next..? .👀👀.

0 · Reply

lonedaddy Apr. 16 at 3:53 PM

$CARA Lets hope this new management can manage wall street better than the last clown show.

0 · Reply

lasmanoz Apr. 16 at 2:12 PM

$CARA they will short this

1 · Reply

TA_Kongen Apr. 16 at 1:03 PM

$CARA Buggy on my end. TVRD is new ticker should have opened at 9am with R/S and merger in effect.

0 · Reply

Market Cap	24.33M
Revenue (ttm)	7.14M
Net Income (ttm)	-70.87M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-992.58%
Debt to Equity Ratio	0.00

Volume	237,100
Avg Vol	21,144
Day's Range	N/A - N/A
Shares Out	4.57M
Stochastic %K	65%
Beta	0.41
Analysts	Strong Sell
Price Target	$96.04